Covered recipient · General Payments record
CHRISTINE D CAIRNS
Allopathic & Osteopathic Physicians Otolaryngology
General Payments · PY2018–2019
$335.19
- Reported across 23 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2019 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $224.11 | 16 |
By paying entity
PY2019 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $55.88 | 4 |
| EISAI INC. | $30.00 | 2 |
| OptiNose US, Inc. | $28.67 | 2 |
| ALK-Abello, Inc | $22.33 | 2 |
| Medtronic USA, Inc. | $21.70 | 1 |
| AERIN MEDICAL INC. | $19.66 | 2 |
| Cook Medical LLC | $19.06 | 1 |
| Regeneron Healthcare Solutions, Inc. | $13.50 | 1 |
| Kaleo, Inc. | $13.31 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2019 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Aerin Medical Inc. | $6.36 | 10/25/2019 | Food and Beverage | Undisputed | 01/23/2026 | 665875951 | CMS |
| Aerin Medical Inc. | $13.30 | 10/28/2019 | Food and Beverage | Undisputed | 01/23/2026 | 665875961 | CMS |
| ALK-Abello, Inc | $11.05 | 10/14/2019 | Food and Beverage | Undisputed | 01/23/2026 | 698047173 | CMS |
| ALK-Abello, Inc | $11.28 | 10/22/2019 | Food and Beverage | Undisputed | 01/23/2026 | 698047317 | CMS |
| Cook Medical LLC | $19.06 | 08/19/2019 | Food and Beverage | Undisputed | 01/23/2026 | 630357249 | CMS |
| EISAI INC. | $15.00 | 04/10/2019 | Food and Beverage | Undisputed | 01/23/2026 | 697006383 | CMS |
| EISAI INC. | $15.00 | 10/09/2019 | Food and Beverage | Undisputed | 01/23/2026 | 697017447 | CMS |
| GENZYME CORPORATION | $13.34 | 07/29/2019 | Food and Beverage | Undisputed | 01/23/2026 | 694107025 | CMS |
| GENZYME CORPORATION | $14.82 | 08/26/2019 | Food and Beverage | Undisputed | 01/23/2026 | 694300669 | CMS |
| GENZYME CORPORATION | $13.34 | 11/11/2019 | Food and Beverage | Undisputed | 01/23/2026 | 694196309 | CMS |
| GENZYME CORPORATION | $14.38 | 11/11/2019 | Food and Beverage | Undisputed | 01/23/2026 | 694319721 | CMS |
| Kaleo, Inc. | $13.31 | 09/23/2019 | Food and Beverage | Undisputed | 01/23/2026 | 693178781 | CMS |
| Medtronic USA, Inc. | $21.70 | 09/16/2019 | Food and Beverage | Undisputed | 01/23/2026 | 708437469 | CMS |
| OptiNose US, Inc. | $14.17 | 05/20/2019 | Food and Beverage | Undisputed | 01/23/2026 | 684251507 | CMS |
| OptiNose US, Inc. | $14.50 | 11/04/2019 | Food and Beverage | Undisputed | 01/23/2026 | 684251565 | CMS |
| Regeneron Healthcare Solutions, Inc. | $13.50 | 10/07/2019 | Food and Beverage | Undisputed | 01/23/2026 | 673355381 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019
- Source files
- Dataset page · Bulk file · PY2018 , PY2019
- Generated from
- OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.